Cargando…
Comparing the evidential strength for psychotropic drugs: a Bayesian meta-analysis
Approval and prescription of psychotropic drugs should be informed by the strength of evidence for efficacy. Using a Bayesian framework, we examined (1) whether psychotropic drugs are supported by substantial evidence (at the time of approval by the Food and Drug Administration), and (2) whether the...
Autores principales: | Pittelkow, Merle-Marie, de Vries, Ymkje Anna, Monden, Rei, Bastiaansen, Jojanneke A., van Ravenzwaaij, Don |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640368/ https://www.ncbi.nlm.nih.gov/pubmed/34620261 http://dx.doi.org/10.1017/S0033291721003950 |
Ejemplares similares
-
Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings
por: Hoek, Joyce M., et al.
Publicado: (2021) -
Bayesian reanalysis of null results reported in medicine: Strong yet variable evidence for the absence of treatment effects
por: Hoekstra, Rink, et al.
Publicado: (2018) -
Bayesian Smoothing of Decision Tree Soft Predictions and Evidential Evaluation
por: Sutton-Charani, Nicolas
Publicado: (2020) -
Evidential meta-model for molecular property prediction
por: Ham, Kyung Pyo, et al.
Publicado: (2023) -
Statistical power in clinical trials of interventions for mood, anxiety, and psychotic disorders
por: de Vries, Ymkje Anna, et al.
Publicado: (2023)